180 related articles for article (PubMed ID: 8762319)
1. Drug induced otalgia due to mesalazine and sulphasalazine.
Wareing M; Mitchell D
J Laryngol Otol; 1996 May; 110(5):466-7. PubMed ID: 8762319
[TBL] [Abstract][Full Text] [Related]
2. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
Rachmilewitz D
BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
[TBL] [Abstract][Full Text] [Related]
3. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
Perrot S; Aslangul E; Szwebel T; Gadhoum H; Romnicianu S; Le Jeunne C
Int J Colorectal Dis; 2007 Sep; 22(9):1119-21. PubMed ID: 17440739
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Rao SS; Cann PA; Holdsworth CD
Scand J Gastroenterol; 1987 Apr; 22(3):332-6. PubMed ID: 2884724
[TBL] [Abstract][Full Text] [Related]
7. Mesalazine in childhood inflammatory bowel disease.
Barden L; Lipson A; Pert P; Walker-Smith JA
Aliment Pharmacol Ther; 1989 Dec; 3(6):597-603. PubMed ID: 2577501
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological bases of therapy with 5-ASA].
Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
[No Abstract] [Full Text] [Related]
9. Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.
Riley SA; Lecarpentier J; Mani V; Goodman MJ; Mandal BK; Turnberg LA
Gut; 1987 Aug; 28(8):1008-12. PubMed ID: 2889648
[TBL] [Abstract][Full Text] [Related]
10. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
Donald IP; Wilkinson SP
Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
[TBL] [Abstract][Full Text] [Related]
11. Lichen planus and mesalazine.
Alstead EM; Wilson AG; Farthing MJ
J Clin Gastroenterol; 1991 Jun; 13(3):335-7. PubMed ID: 1676716
[TBL] [Abstract][Full Text] [Related]
12. [Salazosulfapyridine or 5-aminosalicylic acid].
van Hees PA
Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762
[No Abstract] [Full Text] [Related]
13. Ulcerative colitis: responding to the challenges.
Achkar JP
Cleve Clin J Med; 2007 Sep; 74(9):657-60. PubMed ID: 17879519
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
Ewe K; Eckardt V; Kanzler G
Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA
Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192
[TBL] [Abstract][Full Text] [Related]
16. 5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine.
Stretch GL; Campbell BJ; Dwarakanath AD; Yaqoob M; Stevenson A; Morris AI; Rhodes JM
Aliment Pharmacol Ther; 1996 Dec; 10(6):941-7. PubMed ID: 8971292
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Rutgeerts P
Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
[TBL] [Abstract][Full Text] [Related]
18. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
Gastroenterology; 1988 Jun; 94(6):1383-9. PubMed ID: 2896139
[TBL] [Abstract][Full Text] [Related]
19. Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Birketvedt GS; Berg KJ; Fausa O; Florholmen J
Inflamm Bowel Dis; 2000 Nov; 6(4):275-9. PubMed ID: 11149559
[TBL] [Abstract][Full Text] [Related]
20. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Nakshabendi IM; Duncan A; Russell RI
Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
